Clinical Trials Logo

Clinical Trial Summary

Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05095337
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact
Status Active, not recruiting
Phase Phase 1
Start date June 7, 2022
Completion date July 25, 2022

See also
  Status Clinical Trial Phase
Completed NCT04873063 - Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers Phase 1
Completed NCT05059743 - ADME Study of [14C]- Larotinib in Healthy Male Subjects Phase 1
Completed NCT04616742 - Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers Phase 1
Completed NCT04260373 - Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers. Phase 1
Completed NCT05150717 - ADME Study of [14C]-Jaktinib in Healthy Male Subjects Phase 1
Completed NCT05109078 - ADME Study of [14C]- Rongliflozin in Healthy Male Subjects Phase 1